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Bacillus clausii in treatment of rotavirus infection in children
K a te ry n a  S m iia n 1, O leksandr Sm iya n 1, Tatiana B yn d a 1, A n drij Loboda1 
1Sumy State University, Sumy, Ukraine
Background. Every year, 2 million patients are hospitalized with a severe form of rotavirus 
infection (RVI), 25 million need medical assistance of a doctor and 111 million cases are treated 
at home. The most severe illness occurs in children at the age of 4—36 months of life. Rotavirus 
infection still remains the cause of more than 215 000 deaths annually, especially in low-income 
countries. Probiotics are widely known to be used in acute diarrhoea in children and adults. Today, 
in clinical practice the use probiotic drugs that are normal residents of the intestinal tract, such as 
lactic acid bacteria and spore-forming, mainly representatives of the genus Bacillus.
Objective. The purpose of our research is to study the effectiveness of the use Bacillus clausii 
in children with rotavirus infection by assessing the duration of clinical symptoms.
Methods. We have studied 42 children with RVI between the ages of 1 and 5 years, group I 
consisted of 20 patients received standard treatm ent and group II — 22 patients received additional 
probiotic, which includes Bacillus clausii. The control group consisted of 15 healthy children, rep­
resentative of age and gender. Diagnosis of rotavirus infection was verified according to results of 
the immuno-chromatographic test.
Results. In the examination of patients, DVF syndrome, characterized by diarrhoea, vomiting, 
and fever, was the leading symptom, in addition, the reduction of turgor of skin, pain in the epi­
gastric and umbilical areas with palpation of the abdominal was determined. W hen comparing the 
duration of these symptoms, it was found that in children of group II the fever lasted for 0.61 days, 
vomiting for 0.65 days and diarrhoea for 1.09 days less than for the patients in group I (p
Conclusions. The inclusion of Bacillus clausii in the treatm ent of children with rotavirus in­
fection reduced the duration of the main clinical symptoms. Furtherm ore, the use of a probiotic 
preparation containing Bacillus clausii in the complex treatm ent of rotavirus infection contributed 
to the improvement of treatm ent efficiency.
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